P1121 MATCHING-ADJUSTED INDIRECT COMPARISONS OF EPCORITAMAB VSMOSUNETUZUMAB OR ODRONEXTAMAB IN RELAPSED/REFRACTORYFOLLICULAR LYMPHOMA AFTER ≥2 SYSTEMIC THERAPIES

Kim Linton, et al.

Research output: Contribution to journal › Meeting Abstract › peer-review

Fingerprint

Dive into the research topics of 'P1121 MATCHING-ADJUSTED INDIRECT COMPARISONS OF EPCORITAMAB VSMOSUNETUZUMAB OR ODRONEXTAMAB IN RELAPSED/REFRACTORYFOLLICULAR LYMPHOMA AFTER ≥2 SYSTEMIC THERAPIES'. Together they form a unique fingerprint.

Medicine and Dentistry

Agricultural and Biological Sciences

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology